Efficacy and safety of adjuvant ensartinib in stage I ALK-positive NSCLC patients: a retrospective, multicenter study

Lung Cancer · Elsevier

Аннотация

Publication date: December 2026 Source: Lung Cancer, Volume 222 Author(s): Ziyan Gao, Jian Zheng, Linlin Jia, Wenchao Xia, Yuan Chen, Xiaoping Li, Lin Du, Jing Zhao, Lianmin Zhang, Meng Wang

Читать у издателя →

Похожие статьи